Telix Pharma

Developer of theranostic radiopharmaceuticals for imaging and treating cancer

placeMelbourne, Victoria, Australia calendar_todayFounded 2015 groups234 employees language telixpharma.com

Social engagement

Social engagement: 68.5K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%

Recent activity

2 Jul 2026
Milestone
regulatory
30 Jun 2026
Event
investor education webinar exploring theranostics' potential role in helping address patients with glioma and glioblastoma
29 Jun 2026
Recognition
Coming soon